GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05054751 · COMPLETED
Trial details
- NCT number
- NCT05054751
- Sponsor
- Genor Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2022-12-02
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.